Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $17.49 million. The enterprise value is $24.37 million.
Market Cap | 17.49M |
Enterprise Value | 24.37M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025, before market open.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IBO has 11.50 million shares outstanding. The number of shares has decreased by -14.00% in one year.
Current Share Class | 11.50M |
Shares Outstanding | 11.50M |
Shares Change (YoY) | -14.00% |
Shares Change (QoQ) | +620.17% |
Owned by Insiders (%) | 0.85% |
Owned by Institutions (%) | 1.58% |
Float | 5.16M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.37 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.25, with a Debt / Equity ratio of 1.23.
Current Ratio | 0.25 |
Quick Ratio | 0.20 |
Debt / Equity | 1.23 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.19 |
Financial Efficiency
Return on equity (ROE) is -139.55% and return on invested capital (ROIC) is -7.52%.
Return on Equity (ROE) | -139.55% |
Return on Assets (ROA) | -6.54% |
Return on Invested Capital (ROIC) | -7.52% |
Return on Capital Employed (ROCE) | -32.34% |
Revenue Per Employee | n/a |
Profits Per Employee | -$24.71M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, IBO has paid $33,000 in taxes.
Income Tax | 33,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1.75 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 47.47 |
Average Volume (20 Days) | 8,662,177 |
Short Selling Information
The latest short interest is 9,001, so 0.08% of the outstanding shares have been sold short.
Short Interest | 9,001 |
Short Previous Month | 12,105 |
Short % of Shares Out | 0.08% |
Short % of Float | 0.17% |
Short Ratio (days to cover) | 0.30 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -3.40M |
Pretax Income | -8.34M |
Net Income | -24.71M |
EBITDA | -2.28M |
EBIT | -3.40M |
Earnings Per Share (EPS) | -$2.30 |
Balance Sheet
The company has $2.00 million in cash and $8.88 million in debt, giving a net cash position of -$6.88 million or -$0.60 per share.
Cash & Cash Equivalents | 2.00M |
Total Debt | 8.88M |
Net Cash | -6.88M |
Net Cash Per Share | -$0.60 |
Equity (Book Value) | 7.24M |
Book Value Per Share | 0.35 |
Working Capital | -7.34M |
Cash Flow
Operating Cash Flow | -3.92M |
Capital Expenditures | n/a |
Free Cash Flow | -3.10M |
FCF Per Share | -$0.27 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
IBO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 14.00% |
Shareholder Yield | 14.00% |
Earnings Yield | -141.30% |
FCF Yield | -17.71% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |